| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/29/2011 | CN102106827A Lentinan granule as well as preparation method and use of lentinan granule |
| 06/29/2011 | CN102106823A Resveratrol composite fine particle preparation process applying supercritical fluid crystallization technology |
| 06/29/2011 | CN101862415B Health liquor |
| 06/29/2011 | CN101716346B Supramolecular hydrogel gene vector material, and preparation method and application thereof |
| 06/29/2011 | CN101697996B Chinese herbal medicinal composition for externally treating allergic rhinitis |
| 06/29/2011 | CN101580525B Method for extracting salidroside, polysaccharose and tannin-type substances from rhodiola root crude drugs |
| 06/29/2011 | CN101575383B Preparation method for separating polyose from White Hyacinth Bean |
| 06/29/2011 | CN101530394B Preparation method of polypeptide-chitosan composite nanoparticles loaded with coenzyme Q10 |
| 06/28/2011 | US7968716 Caspase inhibitors and uses thereof |
| 06/28/2011 | US7968680 Polynucleotides encoding members of the human B lymphocyte activation antigen B7 family and polypeptides encoded thereby |
| 06/28/2011 | US7968562 an immune response modifier (IRM) compound 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine; fatty acids such as oleic acid, isostearic acid; hydrophobic, aprotic caprylic/capric triglyceride miscible with fatty acid; actinic keratosis, postsurgical scars, warts, atopic dermatitis |
| 06/28/2011 | US7968560 Compounds that modulate PPARγ-type receptors and cosmetic/pharmaceutical compositions comprising said compounds |
| 06/28/2011 | US7968557 Diseases with abnormal activation of the Abl, BCR-Abl, Bmx, CSK, TrkB, FGFR3, Fes, Lck, B-RAF, C-RAF, MKK6, alpha and beta SAPK2 kinases; antiproliferative; pyrrolo[2,3-d]pyrimidine-7-carboxylic acid [3-phenylcarbamoyl-phenyl]-amides and pyrrolo[3,2-c]pyridine analogs |
| 06/28/2011 | US7968547 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/28/2011 | US7968523 Purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase nucleic acids and polypeptides |
| 06/28/2011 | US7968340 Structural protein of adeno-associated virus with modified antigenicity, its production and its use |
| 06/28/2011 | US7968284 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 06/28/2011 | US7968103 Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components |
| 06/28/2011 | CA2635196C Glucocorticoid receptor modulators |
| 06/28/2011 | CA2467672C Chemokine receptor antagonists and methods of use therefor |
| 06/28/2011 | CA2414772C Prevention and treatment of alzheimer's disease |
| 06/28/2011 | CA2209300C Redirection of cellular immunity by receptor chimeras |
| 06/23/2011 | WO2011074881A2 Substances for inhibiting expression of genes for sensitivity to allergic disorders |
| 06/23/2011 | WO2011074711A1 ADJUVANT CONTAINING β-HEMATIN |
| 06/23/2011 | WO2011073907A1 A polymorph form of nevirapine and its preparation |
| 06/23/2011 | WO2011073277A1 PIPERIDINE ARYL SULFONAMIDE DERIVATIVES AS Kv1.3 MODULATORS |
| 06/23/2011 | WO2011073269A1 Piperidine aryl sulfonamide derivatives as kv1.3 modulators |
| 06/23/2011 | WO2011073218A1 Compositons and methods for inhibiting expression of il-18 genes |
| 06/23/2011 | WO2011073119A1 Mk2 inhibitors |
| 06/23/2011 | WO2011072871A1 Production of ifn-lambda by conventional dendritic cells and uses thereof |
| 06/23/2011 | WO2011072488A1 Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists |
| 06/23/2011 | WO2011051960A3 Process for producing rapamycin derivatives |
| 06/23/2011 | WO2011020024A3 Methods of modulating immune function |
| 06/23/2011 | US20110154521 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 06/23/2011 | US20110152504 CD16A Binding Proteins and Use for the Treatment of Immune Disorders |
| 06/23/2011 | US20110152349 Compositions and methods for inhibiting expression of il-18 genes |
| 06/23/2011 | US20110152346 Use of Oligonucleotides with Modified Bases in Hybridization of Nucleic Acids |
| 06/23/2011 | US20110152338 Cycloalkane[b]indole antagonists of prostaglandin d2 receptors |
| 06/23/2011 | US20110152325 Carboxamide compounds and their use as calpain inhibitors iv |
| 06/23/2011 | US20110152296 Heterocyclic compounds and their uses |
| 06/23/2011 | US20110152275 Agent for maintenance of induced remission |
| 06/23/2011 | US20110152260 Indazole derivatives as modulators of interleukin-1 receptor-associated kinase |
| 06/23/2011 | US20110152242 2,3-Substituted Fused Pyrimidin -4 (3H)-Ones as VR1 Antagonists |
| 06/23/2011 | US20110152241 Novel compounds as receptor modulators with therapeutic utility |
| 06/23/2011 | US20110152240 Pyrazolopyrimidines and related heterocycles as ck2 inhibitors |
| 06/23/2011 | US20110152238 Pharmaceutical compounds |
| 06/23/2011 | US20110152236 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 06/23/2011 | US20110152207 Use of vitamin d glycosides and sulfates for treatment of disease |
| 06/23/2011 | US20110152202 Development of c-reactive protein mutant with improved therapeutic benefit in immune thrombocytopenia and lupus nephritis |
| 06/23/2011 | US20110152201 Emulsion preconcentrates containing cyclosporin or a macrolide |
| 06/23/2011 | US20110152171 Histamine binding protein |
| 06/23/2011 | US20110151480 Methods of purifying zsig33 |
| 06/23/2011 | US20110151434 Adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 06/23/2011 | US20110151015 Immunomodulator particles and methods of treating |
| 06/23/2011 | US20110150987 Mucoadhesive particulate formulation for inducing antigen-specific immune tolerance |
| 06/23/2011 | US20110150981 Compounds for Use in Therapy |
| 06/23/2011 | US20110150975 Treatment of Mammalian Physiological Reaction of IgE Antibodies Present in Said Mammal Upon Contact With the Corresponding Antigen |
| 06/23/2011 | US20110150944 Structured triglycerides and emulsions comprising same |
| 06/23/2011 | US20110150936 Anti-tumoral cells |
| 06/23/2011 | US20110150934 Ovarian Tumor Tissue Cell Preparations/Vaccines for the Treatment/Inhibition of Ovarian Tumors and Ovarian Cancer |
| 06/23/2011 | US20110150931 Rapid responses to delayed booster immunisations |
| 06/23/2011 | US20110150930 Recombinant viral-based malaria vaccines |
| 06/23/2011 | US20110150929 SARS vaccine compositions and methods of making and using them |
| 06/23/2011 | US20110150927 Stabilisation of Viral Microparticles |
| 06/23/2011 | US20110150924 Device, Method, and system for neural modulation as vaccine adjuvant in a vertebrate subject |
| 06/23/2011 | US20110150922 Immunogen platform |
| 06/23/2011 | US20110150920 Allergy Vaccines Containing Hybrid Polypeptides |
| 06/23/2011 | US20110150919 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/23/2011 | US20110150918 Treatment of microbial infections |
| 06/23/2011 | US20110150917 Small Cationic Antimicrobial Peptides |
| 06/23/2011 | US20110150916 Compositions and methods for treatment of group a streptococci |
| 06/23/2011 | US20110150915 Polyvalent vaccine |
| 06/23/2011 | US20110150911 Methods and reagents for treating, preventing and diagnosing bunyavirus infection |
| 06/23/2011 | US20110150910 Methods of inducing an immune response |
| 06/23/2011 | US20110150896 Antibody against PCRV |
| 06/23/2011 | US20110150892 Human antibodies that bind lymphocyte activation gene-3 (lag-3) and uses thereof |
| 06/23/2011 | US20110150880 Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides |
| 06/23/2011 | US20110150879 Specific depletion of cd4+ t cells |
| 06/23/2011 | US20110150878 Compositions and methods for manipulating levels of antigen-specific antibodies in a mammal |
| 06/23/2011 | US20110150873 Anti-inflammatory compositions and combinations |
| 06/23/2011 | US20110150871 Treatment of an autoimmune disease using il-18 antagonists |
| 06/23/2011 | US20110150865 Antibodies to lymphotoxin-alpha |
| 06/23/2011 | US20110150863 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 06/23/2011 | US20110150852 Novel Strain of Lactobacillus Paracasei Subspecies Paracasei Having Antimicrobial and Immunomodulatory Properties |
| 06/23/2011 | US20110150845 Methods and compositions for modulating immunological tolerance |
| 06/23/2011 | US20110150838 Lactobacillus paracasei strain lt12 as immunity regulatory agent |
| 06/23/2011 | US20110150834 Crth2 modulators |
| 06/23/2011 | US20110150830 Covalent conjugates between endoperoxides and transferrin and lactoferrin receptor-binding agents |
| 06/23/2011 | US20110150826 Agent for the treatment and/or prophylaxis of an autoimmune disease and for the formation of regulatory t cells |
| 06/23/2011 | US20110150825 Uses of selective inhibitors of hdac8 for treatment of inflammatory conditions |
| 06/23/2011 | US20110150824 Nutritional Composition for Improving the Mammalian Immune System |
| 06/23/2011 | US20110150820 Methods for covalently attaching a polymer to a methionine residue in proteins and peptides |
| 06/23/2011 | US20110150776 Method for Testing and Treating Delayed Food Allergies |
| 06/23/2011 | US20110150757 Compounds for inhibiting ksp kinesin activity |
| 06/23/2011 | CA2783510A1 Production of ifn-lambda by conventional dendritic cells and uses thereof |
| 06/23/2011 | CA2780290A1 Mk2 inhibitors |
| 06/22/2011 | EP2336321A1 Ox2 receptor homolog |
| 06/22/2011 | EP2336187A2 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations |
| 06/22/2011 | EP2336184A2 Administration of agents for the treatment of inflammation |
| 06/22/2011 | EP2336179A1 Stabilized single domain antibodies |